Quick Summary
Covering the latest research from top Wall Street investment banks

Scorpio X Ramps Ahead of Schedule, Driving Broad Upward Revisions to ALAB Results, Guidance and Price Target

Institution
JPMorgan
Date
2026-08-05
Authors
Harlan Sur, Apoorva Kumar, Mayur Ramdhani
Company
Astera Labs Inc
Ticker
ALAB.US
Industry
Semiconductors
Rating
Overweight
BullishLow confidenceQ2 results and Q3 guidance were significantly above market expectations, Scorpio X is entering large-scale mass production with the AWS Trainium 3 XPU project, while Aries, Taurus and Leo/CXL form multiple growth drivers for 2027.
AuthorsHarlan Sur, Apoorva Kumar, Mayur Ramdhani
Target price$465.00
CoverageUnited States
Business segmentsScorpio interconnect switch chips、Aries PCIe retimers、Taurus smart cable modules、Leo/CXL memory controllers、Custom interconnect chips、Optical interconnect
Research firm divisions/subsidiariesJPMorgan(Other)

AI summary card

Scorpio X Ramps Ahead of Schedule, Driving Broad Upward Revisions to ALAB Results, Guidance and Price Target

Q2 revenue grew 104% year over year, and the midpoint of Q3 revenue guidance implies about 40% sequential growth; JPMorgan is positive on Scorpio X and multiple interconnect product lines sustaining high growth, reiterating Overweight and raising the price target to $465.

Rating: Overweight; price target: $465; prior price target: $280; current price: $361.67; potential upside: about 28.6%.
SemiconductorsArtificial intelligence infrastructureHigh-speed interconnectResults above expectationsEarnings forecast upgradePrice target increase
  • Q2 revenue reached $392 million, up 104% year over year and 27% quarter over quarter, above market expectations of $360 million.
  • Q3 revenue guidance is $540 million to $560 million, with the midpoint implying about 40% sequential growth, significantly above the roughly 15% implied by the market before the earnings release.
  • Scorpio is expected to become the company's largest revenue product family in Q3, one quarter earlier than expected, mainly driven by mass production of Scorpio X in the AWS Trainium 3 XPU project.
  • 2026 and 2027 adjusted EPS forecasts were raised by 28.1% and 52.3%, respectively, to $3.90 and $6.15.
  • The price target was raised from $280 to $465, implying about 28.6% potential upside versus the current price of $361.67.

Report interpretation

Overview

Astera Labs' Q2 results significantly exceeded market expectations, with Scorpio, Aries and Taurus all benefiting from demand for artificial intelligence infrastructure. Scorpio X has begun production shipments and is accelerating mass production with the AWS Trainium 3 XPU project, prompting management to issue Q3 guidance far stronger than expected. JPMorgan accordingly raised its earnings forecasts for 2026 to 2028 substantially, and believes new Scorpio X customers, PCIe Gen 6 and Gen 7 upgrades, Taurus bandwidth evolution, and the ramp of Leo/CXL controllers will jointly support growth in 2027.

Core views

The core view is that the company's growth drivers have expanded from a single product to multiple high-speed interconnect product lines. Scorpio X is ramping faster than previously expected, with more than 10 customer projects underway; Aries benefits from PCIe Gen 6 penetration and early Gen 7 opportunities; Taurus will expand alongside 800G, 1.6T and 3.2T deployments; Leo/CXL has secured a new design win with a U.S. hyperscale customer and is expected to achieve volume shipments in 2027. With high revenue growth and operating leverage, the company is expected to maintain a long-term operating margin of around 40%, but the current valuation already reflects high growth expectations.

Analysis framework

The report first compares Q2 revenue, EPS and margins with consensus expectations, then assesses the Scorpio X mass-production ramp based on Q3 management guidance; it then raises multi-year financial forecasts by incorporating customer projects, technology generations and mass-production timetables across product lines, and finally determines the price target using a peer PEG relative valuation method.

Methodology notes

  • Valuation methodPEG relative valuation

    Peer comparison using price-to-earnings ratios adjusted for earnings growth

    The $465 price target is based on roughly 1x peer PEG, corresponding to about 60x the 2028 adjusted EPS forecast of $7.78.

  • Earnings forecastProduct-line-driven bottom-up forecast

    Forecast revenue and profit based on product mass production, customer adoption and technology upgrade cadence

    The forecast increases mainly reflect stronger Q3 guidance, faster Scorpio X mass production, continued growth in Aries and Taurus, and increased confidence in 2027 opportunities for Leo/CXL, custom chips and optical interconnect.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • ALAB.US
    Core covered company
    Strengths
    Holds a leading position in high-speed interconnect for artificial intelligence servers, with a top market share in PCIe retimers; Scorpio X mass production is accelerating, Aries, Taurus and Leo/CXL form a diversified growth portfolio, and the company has strong operating leverage.
    Weaknesses
    Valuation is at a relatively high level, growth depends on hyperscale customers' platform deployments and timely ramp of new products, and R&D investment requirements are high.
    Comparison
    Q2 revenue and EPS were both above consensus expectations, and the midpoint of Q3 revenue guidance implies about 40% sequential growth, clearly stronger than the market's prior expectation of about 15%.
    Risks
    Slowing demand for artificial intelligence infrastructure, delays in mass production of new products, intensified competition, slower-than-expected customer adoption of new technologies, and higher-than-expected R&D expenses.

Key data

  • Q2 revenue$392 millionUp 104% year over year and 27% quarter over quarter, above market expectations of $360 million.
  • Q2 adjusted EPS$0.80Above market expectations of $0.69.
  • Q2 non-GAAP gross margin73.7%Above market expectations of about 73.0%.
  • Q2 non-GAAP operating margin39.1%Above market expectations of about 36.8%.
  • Q3 revenue guidance$540 million to $560 millionMidpoint of $550 million, implying about 40% sequential growth.
  • Q3 non-GAAP operating margin guidanceAbout 43%Driven by revenue growth and operating leverage.
  • Q3 non-GAAP EPS guidance$1.16 to $1.21Above prior market expectations.
  • 2026 adjusted EPS forecast$3.90Prior estimate $3.04, raised by 28.1%.
  • 2027 adjusted EPS forecast$6.15Prior estimate $4.04, raised by 52.3%.
  • Price target$465Raised from $280; potential upside versus the current price of $361.67 is about 28.6%.

Impact & implications

Results and guidance show that demand for high-speed interconnect products in artificial intelligence accelerated computing platforms remains strong. Scorpio X becoming the largest product family ahead of schedule improves near-term revenue visibility, while Aries, Taurus and Leo/CXL enhance the breadth of growth in 2027. For investors, substantial upward revisions to earnings forecasts and the resonance of multiple product cycles support a positive rating; however, the target valuation of about 60x expected 2028 EPS is relatively high, and the share price will remain highly sensitive to changes in demand, mass-production timing and competition.

Risks

  • Growth in artificial intelligence infrastructure demand may be lower than forecast.
  • Mass production of new products such as Scorpio X and Leo/CXL or customer platform deployments may be delayed.
  • Intensified competition may limit revenue growth and pricing power.
  • Customer adoption of PCIe, CXL and next-generation networking technologies may be slower than expected.
  • Higher-than-expected R&D spending may pressure earnings growth and operating leverage.
  • The current valuation is relatively high; if growth or margins fall short of expectations, the risk of valuation contraction is substantial.

What to watch

  • Mass-production progress and revenue contribution of Scorpio X in the AWS Trainium 3 XPU project.
  • Timing of new customers moving into mass production among the more than 10 Scorpio X customer projects.
  • Whether Scorpio can become the company's largest revenue product family in Q3 as scheduled.
  • Aries PCIe Gen 6 penetration and early PCIe Gen 7 adoption progress.
  • Taurus shipments, attach rates and average selling price changes in 800G, 1.6T and 3.2T platforms.
  • 2027 volume shipment progress for Leo/CXL at two U.S. hyperscale customers.
  • Whether the Q3 gross margin of about 72% and operating margin of about 43% can be achieved.
  • Commercialization progress of custom interconnect chips and NPO/CPO optical interconnect opportunities.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins